- Home
- OXM vs BCYC Comparison
OXM vs BCYC Comparison
Compare OXM & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXM
- BCYC
- Stock Information
- Founded
- OXM 1942
- BCYC 2009
- Country
- OXM United States
- BCYC United Kingdom
- Employees
- OXM N/A
- BCYC N/A
- Industry
- OXM Apparel
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- OXM Consumer Discretionary
- BCYC Health Care
- Exchange
- OXM Nasdaq
- BCYC Nasdaq
- Market Cap
- OXM 672.2M
- BCYC 581.7M
- IPO Year
- OXM N/A
- BCYC 2019
- Fundamental
- Price
- OXM $54.24
- BCYC $8.24
- Analyst Decision
- OXM Hold
- BCYC Buy
- Analyst Count
- OXM 5
- BCYC 10
- Target Price
- OXM $59.00
- BCYC $25.00
- AVG Volume (30 Days)
- OXM 431.3K
- BCYC 370.6K
- Earning Date
- OXM 06-11-2025
- BCYC 05-01-2025
- Dividend Yield
- OXM 5.19%
- BCYC N/A
- EPS Growth
- OXM 53.66
- BCYC N/A
- EPS
- OXM 5.87
- BCYC N/A
- Revenue
- OXM $1,516,601,000.00
- BCYC $25,722,000.00
- Revenue This Year
- OXM N/A
- BCYC N/A
- Revenue Next Year
- OXM $2.59
- BCYC $0.27
- P/E Ratio
- OXM $9.06
- BCYC N/A
- Revenue Growth
- OXM N/A
- BCYC N/A
- 52 Week Low
- OXM $42.12
- BCYC $6.10
- 52 Week High
- OXM $111.46
- BCYC $28.67
- Technical
- Relative Strength Index (RSI)
- OXM 54.93
- BCYC 51.06
- Support Level
- OXM $46.83
- BCYC $7.95
- Resistance Level
- OXM $55.57
- BCYC $9.55
- Average True Range (ATR)
- OXM 2.32
- BCYC 0.72
- MACD
- OXM 1.24
- BCYC 0.06
- Stochastic Oscillator
- OXM 91.14
- BCYC 50.00
About OXM Oxford Industries Inc.
Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company generates majority of its revenue from the Tommy Bahama division.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.